Literature DB >> 21138492

Waist circumference modifies the relationship between the adipose tissue cytokines leptin and adiponectin and all-cause and cardiovascular mortality in haemodialysis patients.

C Zoccali1, M Postorino, C Marino, P Pizzini, S Cutrupi, G Tripepi.   

Abstract

BACKGROUND: the relationships between the adipose tissue cytokines leptin and adiponectin (ADPN) and clinical outcomes have not been well studied in haemodialysis (HD) patients and remain highly controversial. As central obesity is an important modifier of the effect of various risk factors for clinical outcomes, we tested the hypothesis that waist circumference (WC) modifies the link between these cytokines and both overall and cardiovascular death in HD patients.
METHODS: a total of 537 HD patients participated in a prospective cohort study.
RESULTS: leptin and ADPN were inversely related to each other and robustly associated with WC (P < 0.001). During follow-up (average 29 months, range 1-47 months) 182 patients died, including 115 from cardiovascular causes. In analyses adjusting for potential confounders, there were strong interactions between leptin and WC in relationship to both all-cause (P < 0.001) and cardiovascular death (P = 0.002). Accordingly, a fixed excess of leptin signalled a gradually increasing risk for all-cause and cardiovascular mortality in patients with a large WC but an opposite effect in those with a relatively small WC. An interaction between ADPN and WC for all-cause (P = 0.01) and cardiovascular mortality (P = 0.01) emerged only in models excluding the leptin-WC interaction, suggesting that these adipokines share a common pathway leading to adverse clinical events in HD patients.
CONCLUSIONS: the predictive value of leptin and ADPN for all-cause and cardiovascular death in HD patients appears to be critically dependent on WC. These findings support the hypothesis that disturbances in adipokine levels are involved in adverse clinical outcomes in HD patients with abdominal obesity.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21138492     DOI: 10.1111/j.1365-2796.2010.02288.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  16 in total

1.  Usefulness of the conicity index together with the conjoint use of adipocytokines and nutritional-inflammatory markers in hemodialysis patients.

Authors:  Mar Ruperto; Guillermina Barril; Francisco J Sánchez-Muniz
Journal:  J Physiol Biochem       Date:  2016-10-13       Impact factor: 4.158

2.  Association of Adiponectin With Body Composition and Mortality in Hemodialysis Patients.

Authors:  Connie M Rhee; Danh V Nguyen; Hamid Moradi; Steven M Brunelli; Ramanath Dukkipati; Jennie Jing; Tracy Nakata; Csaba P Kovesdy; Gregory A Brent; Kamyar Kalantar-Zadeh
Journal:  Am J Kidney Dis       Date:  2015-03-29       Impact factor: 8.860

Review 3.  Leptin, cardiovascular diseases and type 2 diabetes mellitus.

Authors:  Niki Katsiki; Dimitri P Mikhailidis; Maciej Banach
Journal:  Acta Pharmacol Sin       Date:  2018-06-07       Impact factor: 6.150

Review 4.  Body composition in chronic kidney disease.

Authors:  Kirsten L Johansen; Carol Lee
Journal:  Curr Opin Nephrol Hypertens       Date:  2015-05       Impact factor: 2.894

5.  Abdominal obesity and hypertension: a double burden to the heart.

Authors:  Paweł Krzesiński; Adam Stańczyk; Katarzyna Piotrowicz; Grzegorz Gielerak; Beata Uziębło-Zyczkowska; Andrzej Skrobowski
Journal:  Hypertens Res       Date:  2016-01-21       Impact factor: 3.872

6.  Waist circumference as a predictor of adiponectin levels in peritoneal dialysis patients: a 12-month follow-up study.

Authors:  Ana Paula Bazanelli; Maria Ayako Kamimura; Maria Eugenia Fernandes Canziani; Silvia Regina Manfredi; Lilian Cuppari
Journal:  Perit Dial Int       Date:  2012-09-01       Impact factor: 1.756

Review 7.  Cardiac troponin and C-reactive protein for predicting all-cause and cardiovascular mortality in patients with chronic kidney disease: a meta-analysis.

Authors:  Wei-Jie Li; Xu-Miao Chen; Xiao-Ying Nie; Jing Zhang; Yun-Jiu Cheng; Xiao-Xiong Lin; Su-Hua Wu
Journal:  Clinics (Sao Paulo)       Date:  2015-04       Impact factor: 2.365

8.  Obesity as an effect modifier of the association between leptin and diabetic kidney disease.

Authors:  Ko Hanai; Tetsuya Babazono; Michino Takagi; Naoshi Yoshida; Izumi Nyumura; Kiwako Toya; Nobue Tanaka; Yasuko Uchigata
Journal:  J Diabetes Investig       Date:  2013-09-30       Impact factor: 4.232

9.  The role of serum magnesium and calcium on the association between adiponectin levels and all-cause mortality in end-stage renal disease patients.

Authors:  Anastasia Markaki; John Kyriazis; Kostas Stylianou; George A Fragkiadakis; Kostas Perakis; Andrew N Margioris; Emmanuel S Ganotakis; Eugene Daphnis
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

10.  Visceral adiposity index and risks of cardiovascular events and mortality in prevalent hemodialysis patients.

Authors:  Hung-Yuan Chen; Yen-Ling Chiu; Yi-Fang Chuang; Shih-Ping Hsu; Mei-Fen Pai; Ju-Yeh Yang; Yu-Sen Peng
Journal:  Cardiovasc Diabetol       Date:  2014-10-04       Impact factor: 9.951

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.